Nilandron and Loose tooth - a phase IV clinical study of FDA data

Summary:

Loose tooth is reported as a side effect among people who take Nilandron (nilutamide), especially for people who are male, 50-59 old, also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Loose tooth when taking Nilandron. It is created by eHealthMe based on reports of 204 people who have side effects when taking Nilandron from the FDA, and is updated regularly.

What is Nilandron?

Nilandron has active ingredients of nilutamide. eHealthMe is studying from 206 Nilandron users. Check the latest studies of Nilandron.

What is Loose tooth?

Loose tooth is found to be associated with 730 drugs and 562 conditions by eHealthMe. Check the latest studies of Loose tooth.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

204 people reported to have side effects when taking Nilandron.
Among them, 21 people (10.29%) have Loose tooth.

Among these 21 people:

What is the gender of people who have Loose tooth when taking Nilandron? *

female: 0.0 %
male: 100 %

What is the age of people who have Loose tooth when taking Nilandron? *

What are other drugs people take besides Nilandron? *

What are other side effects people have besides Loose tooth? *

Pain In Jaw: 20 people, 95.24%
Abscess Jaw (tooth abscess or root abscess): 20 people, 95.24%
Hypophagia (reduced food intake): 20 people, 95.24%
Purulent Discharge (discharge that contains pus): 18 people, 85.71%
Depression: 18 people, 85.71%
Malignant Neoplasm Progression (cancer tumour came back): 18 people, 85.71%
Metastases To Bone (cancer spreads to bone): 16 people, 76.19%
Hypotension (abnormally low blood pressure): 16 people, 76.19%
Metastases To Spine (cancer spreads to spine): 15 people, 71.43%
Pain: 15 people, 71.43%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 21 people, 100.00%
Prostate Cancer: 8 people, 38.10%
Pain: 2 people, 9.52%
Type 2 Diabetes: 1 person, 4.76%
Sleep Disorder: 1 person, 4.76%
Osteoporosis (bones weak and more likely to break): 1 person, 4.76%
Nausea (feeling of having an urge to vomit): 1 person, 4.76%
High Blood Cholesterol: 1 person, 4.76%
Erection Problems: 1 person, 4.76%
Depression: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Nilandron and have Loose tooth?

- Check whether Loose tooth is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nilandron:

Nilandron (206 reports)

Loose tooth treatments and more:

Loose tooth (5,115 reports)

Browse all side effects of Nilandron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Loose tooth:

Loose tooth (730 drugs)

Browse all the conditions that are associated with Loose tooth:

Loose tooth (562 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nilutamide (the active ingredients of Nilandron) and Nilandron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.